Dear Colleagues and Friends,
We cordially invite you to participate in a survey aimed at understanding the current practices, perceptions, and challenges related to Homologous Recombination Deficiency (HRD) and BRCA testing in ovarian cancer. Your responses will provide valuable insights that can help improve the quality of patient care and treatment strategies. The survey will take no more than 5 minutes of your time to complete (promised). The results will be evaluated anonymously and in a statistically aggregated form.

Thank you for your help and continued work and support.

Yours sincerely,

ESGO, ENYGO, and ESMO Young Oncologists Committee
Section 1: Demographics and Practice Setting

Question Title

* 1. What is your age?

Question Title

* 2. What is your gender?

Question Title

* 3. What is your primary specialty?

Question Title

* 4. How many years have you been practicing in your specialty?

Question Title

* 5. In what type of healthcare setting do you primarily practice?

Question Title

* 6. In which country do you practice?

Question Title

* 7. How many ovarian cancer patients does your site treat per year?

Question Title

* 8. Which clinical guidelines do you follow for HRD and BRCA testing in ovarian cancer?
(select all that apply)

Page1 / 4
 
 25% of survey complete.

T